Publications by authors named "Georg M Haag"

Claim this Profile
A
A NECessary Workup: Exploring the Rare Histology of an Esophageal Tumor.
Ronald Koschny, Georg Martin Haag, Alexander Brobeil

United European Gastroenterol J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individually compounded multi-chamber vs. standardized parenteral nutrition bags in solid tumors-A randomized clinical trial (IKF-010).
Thorsten Oliver Goetze, Ralf-Dieter Hofheinz, Ingeborg Roetzer, Wolfgang Blau, Thomas Zander, Georg Martin Haag

Clin Nutr ESPEN· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to the Letter to the Editor: Critical appraisal of the IKF-010 trial.
Salah-Eddin Al-Batran, Thorsten Oliver Goetze, Georg Martin Haag

Clin Nutr ESPEN· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-Blockers Influence Oncological Outcomes in Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy Based on the Pathological Subtype: A Retrospective Cohort Study.
Nerma Crnovrsanin, Sarah Zumsande, Ingmar Florin Rompen, Sabine Schiefer, Sarah Zimmer, Georg Martin Haag

Ann Surg Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: The Role of Beta-Blockers in Gastric Cancer-A Pathway to Personalized Therapy?
Nerma Crnovrsanin, Sarah Zumsande, Ingmar F Rompen, Sabine Schiefer, Sarah Zimmer, Georg Martin Haag

Ann Surg Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of placental growth factor as a biomarker in patients with resectable gastric cancer.
Ingmar F Rompen, Daniel Nerz, Nerma Crnovrsanin, Wenjun Hu, Sarah Zimmer, Georg Martin Haag

J Gastrointest Surg· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of multiprofessional care for young colorectal cancer patients: a qualitative Study.
Kaiyu Xu, Charlotte Flock, Katja Kaunath, Nathalie Schmitt, Constantin Bienen, Georg Martin Haag

Oncologist· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Relevance of the Proximal Resection Margin Distance in Distal Gastrectomy for Gastric Adenocarcinoma.
Ingmar F Rompen, Isabel Schütte, Nerma Crnovrsanin, Sabine Schiefer, Adrian T Billeter, Georg Martin Haag

Ann Surg Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: The Prognostic Relevance of the Proximal Resection Margin Distance is Dependent upon the Histological Subtype of Gastric Adenocarcinoma.
Ingmar F Rompen, Isabel Schütte, Nerma Crnovrsanin, Sabine Schiefer, Adrian T Billeter, Georg Martin Haag

Ann Surg Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electronic health intervention to manage symptoms of immunotherapy in patients with cancer (SOFIA): Results from a randomized controlled pilot trial.
Christina Sauer, Stefanie Zschäbitz, Jürgen Krauss, Thomas Walle, Georg Martin Haag

Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is neoadjuvant chemotherapy followed by surgery the appropriate treatment for esophagogastric signet ring cell carcinomas? A systematic review and meta-analysis.
Sabine Schiefer, Nerma Crnovrsanin, Eva Kalkum, Johannes A Vey, Henrik Nienhüser, Georg M Haag

Front Surg· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
Sylvie Lorenzen, Thorsten Oliver Götze, Peter Thuss-Patience, Matthias Biebl, Nils Homann, Georg Martin Haag

J Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Burnout Prevalence among German Physicians Working in a Palliative Care Setting: A Survey of the AIO Quality of Life Working Group.
Lena Herbrand, Wolf-Karsten Hofmann, Ralf-Dieter Hofheinz, Sylvia Büttner, Georg Martin Haag

Oncol Res Treat· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold.
Tim Schmäche, Juliane Fohgrub, Anna Klimova, Karin Laaber, Stephan Drukewitz, Georg M Haag

Mol Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pattern and time point of relapse in locally advanced esophagogastric adenocarcinoma after multimodal treatment: implications for a useful structured follow-up.
Ramona Stelmach, Leonidas Apostolidis, Steffen Kahle, Leila Sisic, Henrik Nienhüser, Georg Martin Haag

J Cancer Res Clin Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321).
Joseph Tintelnot, Alexander Stein, Salah-Eddin Al-Batran, Thomas Ettrich, Thorsten Götze, Georg Martin Haag

Front Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining Poly-(ARD-Ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma.
Jule Cecilia Artzenroth, Joseph Tintelnot, Georg Martin Haag, Eray Gökkurt, Johann Steffens

Oncol Res Treat· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Oncological Outcomes of Surgically Treated Early-Onset Gastric Adenocarcinoma - a Retrospective Cohort Study.
Ingmar F Rompen, Henrik Nienhüser, Nerma Crnovrsanin, Julian Musa, Georg Martin Haag

J Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment.
Leonidas Apostolidis, Kristin Lang, Leila Sisic, Elena Busch, Aysel Ahadova, Georg Martin Haag

J Cancer Res Clin Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective.
Leila Sisic, Nerma Crnovrsanin, Henrik Nienhueser, Jin-On Jung, Sabine Schiefer, Georg Martin Haag

Langenbecks Arch Surg· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simple approach for detecting HLA-A*02 alleles in archival formalin-fixed paraffin-embedded tissue samples and an application example for studying cancer immunoediting.
Johannes Witt, Saskia Haupt, Aysel Ahadova, Lena Bohaumilitzky, Vera Fuchs, Georg Martin Haag

HLA· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group.
Ralf-Dieter Hofheinz, Kirsten Merx, Georg M Haag, Christoph Springfeld, Thomas Ettrich

J Clin Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.
Thomas Walle, Sunanjay Bajaj, Joscha A Kraske, Thomas Rösner, Christiane S Cussigh, Georg M Haag

Nat Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.
Thomas Walle, Sunanjay Bajaj, Joscha A Kraske, Thomas Rösner, Christiane S Cussigh, Georg M Haag

Nat Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trial.
Georg Martin Haag, Christoph Springfeld, Barbara Grün, Leonidas Apostolidis, Stefanie Zschäbitz

Eur J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis